Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0001415889-25-002981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-02-03 | MIRM | Peetz Christopher | CEO, Dir | S - Sale | $48.22 | -9,102 | 115.9K | -7% | -$438.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | S | D | 9,102 | $48.22 | 115,920 | D | — | — |